12/19
08:26 am
rdy
Dr. Reddy's Laboratories Limited (NYSE: RDY) was downgraded by analysts at Nomura from a "buy" rating to a "neutral" rating.
Low
Report
Dr. Reddy's Laboratories Limited (NYSE: RDY) was downgraded by analysts at Nomura from a "buy" rating to a "neutral" rating.
12/13
11:32 am
rdy
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio [Yahoo! Finance]
Low
Report
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio [Yahoo! Finance]
12/11
06:04 pm
rdy
Heparin Market to Grow by USD 3.34 Billion (2024-2028), Driven by Coagulation Disorder Prevalence and AI Impacting Market Trends - Technavio [Yahoo! Finance]
Low
Report
Heparin Market to Grow by USD 3.34 Billion (2024-2028), Driven by Coagulation Disorder Prevalence and AI Impacting Market Trends - Technavio [Yahoo! Finance]
12/10
08:20 am
rdy
Theranica Advances Migraine Care in 2024 Supported by New Research, an Expanded Indication, a new Chief Medical Officer, and Broader Insurance Coverage [Yahoo! Finance]
Low
Report
Theranica Advances Migraine Care in 2024 Supported by New Research, an Expanded Indication, a new Chief Medical Officer, and Broader Insurance Coverage [Yahoo! Finance]
12/6
11:02 pm
rdy
Dr. Reddy's Laboratories Limited (NYSE: RDY) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Low
Report
Dr. Reddy's Laboratories Limited (NYSE: RDY) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
12/4
07:15 am
rdy
Coccidioidomycosis Drugs Market to Reach US$ 634.3 Million by 2034, Expanding at a CAGR of 4.9% | Fact.MR Report [Yahoo! Finance]
Low
Report
Coccidioidomycosis Drugs Market to Reach US$ 634.3 Million by 2034, Expanding at a CAGR of 4.9% | Fact.MR Report [Yahoo! Finance]
12/2
11:49 am
rdy
Here's Why You Should Add Dr. Reddy's Stock to Your Portfolio [Yahoo! Finance]
Low
Report
Here's Why You Should Add Dr. Reddy's Stock to Your Portfolio [Yahoo! Finance]
11/29
12:04 pm
rdy
RDY Launches Loqtorzi Biosimilar in India for Nasopharyngeal Carcinoma [Yahoo! Finance]
Low
Report
RDY Launches Loqtorzi Biosimilar in India for Nasopharyngeal Carcinoma [Yahoo! Finance]
11/28
06:22 am
rdy
Dr. Reddy's launches Toripalimab in India, the first and only immuno-oncology drug approved for the treatment of nasopharyngeal carcinoma [Yahoo! Finance]
Low
Report
Dr. Reddy's launches Toripalimab in India, the first and only immuno-oncology drug approved for the treatment of nasopharyngeal carcinoma [Yahoo! Finance]
11/28
06:15 am
rdy
Dr. Reddy's launches Toripalimab in India, the first and only immuno-oncology drug approved for the treatment of nasopharyngeal carcinoma
Low
Report
Dr. Reddy's launches Toripalimab in India, the first and only immuno-oncology drug approved for the treatment of nasopharyngeal carcinoma
11/27
09:40 am
rdy
Lung Cancer Therapeutics Market Analysis by treatment into Chemotherapy, Targeted Therapy, Radiotherapy and Biological Therapy Through 2034 | Future Market Insights, Inc. [Yahoo! Finance]
Low
Report
Lung Cancer Therapeutics Market Analysis by treatment into Chemotherapy, Targeted Therapy, Radiotherapy and Biological Therapy Through 2034 | Future Market Insights, Inc. [Yahoo! Finance]
11/26
08:16 am
rdy
Dr. Reddy's Laboratories and Senores Pharmaceuticals, Inc. Announce the Launch of Ivermectin Tablets USP, 3 mg in US Market [Yahoo! Finance]
Low
Report
Dr. Reddy's Laboratories and Senores Pharmaceuticals, Inc. Announce the Launch of Ivermectin Tablets USP, 3 mg in US Market [Yahoo! Finance]
11/26
08:07 am
rdy
Dr. Reddy's Laboratories and Senores Pharmaceuticals, Inc. Announce the Launch of Ivermectin Tablets USP, 3 mg in US Market
Low
Report
Dr. Reddy's Laboratories and Senores Pharmaceuticals, Inc. Announce the Launch of Ivermectin Tablets USP, 3 mg in US Market
11/19
08:20 am
rdy
Coya Therapeutics CEO Dr. Arun Swaminathan Issues Letter to Stockholders [Yahoo! Finance]
Low
Report
Coya Therapeutics CEO Dr. Arun Swaminathan Issues Letter to Stockholders [Yahoo! Finance]
11/13
03:01 am
rdy
Dr. Reddy's Laboratories Limited (NYSE: RDY) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Low
Report
Dr. Reddy's Laboratories Limited (NYSE: RDY) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
11/7
03:01 pm
rdy
Pulmonary Arterial Hypertension Drugs Market to Grow by USD 2.26 Billion from 2024-2028, as Rising PAH Prevalence Drives Demand with AI Redefining Market Landscape - Technavio [Yahoo! Finance]
Low
Report
Pulmonary Arterial Hypertension Drugs Market to Grow by USD 2.26 Billion from 2024-2028, as Rising PAH Prevalence Drives Demand with AI Redefining Market Landscape - Technavio [Yahoo! Finance]
11/6
11:24 am
rdy
Dr. Reddy's Q2 Earnings Miss Estimates, Global Generics Revenues Grow [Yahoo! Finance]
Low
Report
Dr. Reddy's Q2 Earnings Miss Estimates, Global Generics Revenues Grow [Yahoo! Finance]
11/6
09:30 am
rdy
Dr. Reddy's Laboratories Limited (NYSE: RDY) had its price target lowered by analysts at Barclays PLC from $17.40 to $17.00. They now have an "overweight" rating on the stock.
Low
Report
Dr. Reddy's Laboratories Limited (NYSE: RDY) had its price target lowered by analysts at Barclays PLC from $17.40 to $17.00. They now have an "overweight" rating on the stock.
11/6
02:22 am
rdy
Dr Reddy's Laboratories Ltd (RDY) (HY 2025) Earnings Call Highlights: Strong Revenue Growth and ... [Yahoo! Finance]
Low
Report
Dr Reddy's Laboratories Ltd (RDY) (HY 2025) Earnings Call Highlights: Strong Revenue Growth and ... [Yahoo! Finance]
11/5
11:06 pm
rdy
Dr. Reddy's Laboratories Limited (NYSE: RDY) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Low
Report
Dr. Reddy's Laboratories Limited (NYSE: RDY) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
11/4
03:01 pm
rdy
Systemic Mastocytosis Treatment Market to Grow by USD 157.1 Million from 2024-2028, Driven by Aging Population and AI-Redefined Market Landscape - Technavio [Yahoo! Finance]
Low
Report
Systemic Mastocytosis Treatment Market to Grow by USD 157.1 Million from 2024-2028, Driven by Aging Population and AI-Redefined Market Landscape - Technavio [Yahoo! Finance]
10/25
07:44 am
rdy
Dr. Reddy's Named by Science Magazine in Top 20 Global Pharma Employers List for Third Consecutive Year [Yahoo! Finance]
Low
Report
Dr. Reddy's Named by Science Magazine in Top 20 Global Pharma Employers List for Third Consecutive Year [Yahoo! Finance]
10/25
07:40 am
rdy
Dr. Reddy's Named by Science Magazine in Top 20 Global Pharma Employers List for Third Consecutive Year
Low
Report
Dr. Reddy's Named by Science Magazine in Top 20 Global Pharma Employers List for Third Consecutive Year
10/15
06:38 am
rdy
Junshi Biosciences Announces Toripalimab Obtained Approval for Marketing in India and China's Hong Kong SAR [Financial Post (Toronto, Ontario, Canada)]
Low
Report
Junshi Biosciences Announces Toripalimab Obtained Approval for Marketing in India and China's Hong Kong SAR [Financial Post (Toronto, Ontario, Canada)]
10/14
09:52 am
rdy
Dr. Reddy's Launches Comprehensive Menopause Support Program and Training for Employees During Menopause Awareness Month [Yahoo! Finance]
Low
Report
Dr. Reddy's Launches Comprehensive Menopause Support Program and Training for Employees During Menopause Awareness Month [Yahoo! Finance]